Indofarma Tbk. vs Surya Semesta Internusa Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Surya Semesta Internusa Tbk. trades at Rp1,695 (market cap 8.23T, 25.63M 24h volume). The key difference: Surya Semesta Internusa Tbk. is far larger — about 21.1× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | SSIA | |
|---|---|---|
Market Cap | 390.51B | 8.23T |
Volume | — | 25.63M |
Lot | — | 256.3K |
Turnover | — | 43.66B |
Average Price | — | 1,703.42 |
Value | — | 43.66B |
Indicative Equilibrium Price | — | 1,695 |
Indicative Equilibrium Volume | — | 2.72K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT. Surya Semesta Internusa Tbk (formerly known as PT. Multi Investment Ltd.) was established based on notarial deed No. 37 dated June 15, 1971 of Umi Sutamto, S.H., notary in Jakarta. It is a publicly-listed company engaged in investment in the shares of subsidiaries that develop and manage industrial and real estate, provide construction services, manufacture and market pre-cast and pre-stressed concrete and own hotels.
Read more on SSIA →